Paul Leonard

Associate Professor in Biotherapeutics at Dublin City University (DCU) leading research in biomolecular interaction analysis, technology development (including software and hardware), single cell analysis, biologics discovery and diagnostics across multiple application areas including oncology, cardiovascular and infectious disease (Sept 2023 - present).

Innovative entrepreneur and technology inventor with 20 year’s post Ph.D. experience in academic and industrial research and senior management roles in clinical and pre-clinical stage companies. Co-founder and previous CSO/CTO of Remedy Biologics Ltd. Spun the company out of Dublin City University, raising >€15M in non-dilutive and equity-based financing (Feb 2017 to July 2023).

Research interests include:

(i) Single-cell analysis for biological discovery

(ii) Technologies for improved antibody and cell therapy discovery

(iii) High throughput biomolecular interaction technologies and studies

(iv) Immunoassay development and validation for biomedical and environmental analysis